Portfolio Holdings Detail for ISIN IE00BYXG2H39
Stock Name / Fund iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
Issuer Blackrock
Entity holding fund iShares IV Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF Ticker BTEC(USD) LSE
ETF Ticker BTEK(GBP) LSE
ETF Ticker 2B70(EUR) F
ETF Ticker 2B70.DE(EUR) CXE
ETF Ticker BTEC.LS(USD) CXE
ETF Ticker BTEK.LS(GBP) CXE
ETF Ticker BTEC.L(GBP) LSE
ETF Ticker BTEK.L(GBP) LSE

Holdings detail for UTHR

Stock Name	United Therapeutics Corporation
Ticker	UTHR(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US91307C1027
LEI	5299005C4HZL4UWROC14

Show aggregate UTHR holdings

News associated with UTHR

Cantor Fitzgerald Increases United Therapeutics (NASDAQ:UTHR) Price Target to $525.00: United Therapeutics (NASDAQ:UTHR – Free Report) had its target price lifted by Cantor Fitzgerald from $405.00 to $525.00 in a research note published on Wednesday morning,Benzinga reports. Cantor Fitzgerald currently has an overweight rating on the biotechnology company’s stock. A number of other equities analysts also recently issued reports on the company. Jefferies Financial Group […] - 2025-09-11 04:46:17
United Therapeutics (NASDAQ:UTHR) Price Target Raised to $575.00 at Oppenheimer: United Therapeutics (NASDAQ:UTHR – Free Report) had its price objective raised by Oppenheimer from $510.00 to $575.00 in a research report released on Friday morning,Benzinga reports. The firm currently has an outperform rating on the biotechnology company’s stock. Several other analysts have also weighed in on the company. JPMorgan Chase & Co. cut their price […] - 2025-09-08 02:46:57
HC Wainwright Increases United Therapeutics (NASDAQ:UTHR) Price Target to $500.00: United Therapeutics (NASDAQ:UTHR – Free Report) had its target price upped by HC Wainwright from $400.00 to $500.00 in a research note published on Friday morning,Benzinga reports. The firm currently has a buy rating on the biotechnology company’s stock. HC Wainwright also issued estimates for United Therapeutics’ FY2027 earnings at $28.37 EPS. Several other analysts […] - 2025-09-08 02:46:54
United Therapeutics Corporation (NASDAQ:UTHR) Short Interest Up 82.2% in August: United Therapeutics Corporation (NASDAQ:UTHR – Get Free Report) saw a significant increase in short interest in the month of August. As of August 15th, there was short interest totaling 2,860,000 shares, anincreaseof82.2% from the July 31st total of 1,570,000 shares. Currently,6.5% of the shares of the company are short sold. Based on an average daily […] - 2025-09-08 02:15:08
United Therapeutics (NASDAQ:UTHR) Shares Down 4.8% Following Insider Selling: United Therapeutics Corporation (NASDAQ:UTHR – Get Free Report) shares were down 4.8% during mid-day trading on Wednesday following insider selling activity. The stock traded as low as $385.50 and last traded at $385.45. Approximately 497,022 shares were traded during trading, a decline of 9% from the average daily volume of 547,000 shares. The stock had […] - 2025-09-05 02:16:54
Insider Selling: United Therapeutics (NASDAQ:UTHR) Director Sells 3,000 Shares of Stock: United Therapeutics Corporation (NASDAQ:UTHR – Get Free Report) Director Christopher Causey sold 3,000 shares of the business’s stock in a transaction that occurred on Tuesday, September 2nd. The stock was sold at an average price of $423.21, for a total value of $1,269,630.00. Following the transaction, the director owned 4,865 shares in the company, valued […] - 2025-09-04 05:22:59
Stocks Retreat as Bond Yields Climb: The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed down by -0.69%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down by -0.55%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down by -0.79%. September E-mini S&P futures (ESU25 ) fell -0.65%, and September... - 2025-09-03 14:33:33
Stocks Retreat as Bond Yields Climb: The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed down by -0.69%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down by -0.55%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down by -0.79%. September E-mini S&P futures (ESU25 ) fell -0.65%, and September... - 2025-09-03 13:44:52
Stocks Retreat as Bond Yields Climb: The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed down by -0.69%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down by -0.55%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down by -0.79%. September E-mini S&P futures (ESU25 ) fell -0.65%, and September... - 2025-09-03 12:52:53
Stocks Retreat as Bond Yields Climb: The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed down by -0.69%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down by -0.55%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down by -0.79%. September E-mini S&P futures (ESU25 ) fell -0.65%, and September... - 2025-09-03 12:27:04
Stocks Retreat as Bond Yields Climb: The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed down by -0.69%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down by -0.55%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down by -0.79%. September E-mini S&P futures (ESU25 ) fell -0.65%, and September... - 2025-09-03 10:14:11
UTHR Crosses Above Average Analyst Target: In recent trading, shares of United Therapeutics Corp (Symbol: UTHR) have crossed above the average analyst 12-month target price of $382.58, changing hands for $404.81/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgr - 2025-09-03 08:28:18
Stocks Retreat as Bond Yields Climb: The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed down by -0.69%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down by -0.55%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down by -0.79%. September E-mini S&P futures (ESU25 ) fell -0.65%, and September... - 2025-09-03 08:10:07
Stocks Retreat as Bond Yields Climb: The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed down by -0.69%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down by -0.55%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down by -0.79%. September E-mini S&P futures (ESU25 ) fell -0.65%, and September... - 2025-09-03 06:59:07
Stocks Retreat as Bond Yields Climb: The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed down by -0.69%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down by -0.55%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down by -0.79%. September E-mini S&P futures (ESU25 ) fell -0.65%, and September... - 2025-09-03 05:15:06
Stocks Retreat as Bond Yields Climb: The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed down by -0.69%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down by -0.55%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down by -0.79%. September E-mini S&P futures (ESU25 ) fell -0.65%, and September... - 2025-09-03 04:43:16
Stocks Retreat as Bond Yields Climb: The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed down by -0.69%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down by -0.55%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down by -0.79%. September E-mini S&P futures (ESU25 ) fell -0.65%, and September... - 2025-09-03 03:40:04
Stocks Retreat as Bond Yields Climb: The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed down by -0.69%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down by -0.55%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down by -0.79%. September E-mini S&P futures (ESU25 ) fell -0.65%, and September... - 2025-09-03 01:21:35
Stocks Tumble on Higher Bond Yields: The S&P 500 Index ($SPX ) (SPY ) today is down by -1.26%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down by -1.23%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down by -1.38%. September E-mini S&P futures (ESU25 ) are down -1.25%, and September... - 2025-09-02 20:15:06
Stocks Under Pressure from Higher Bond Yields: The S&P 500 Index ($SPX ) (SPY ) today is down by -1.15%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down by -0.83%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down by -1.32%. September E-mini S&P futures (ESU25 ) are down -1.15%, and September... - 2025-09-02 17:45:25
Stocks Under Pressure from Higher Bond Yields: The S&P 500 Index ($SPX ) (SPY ) today is down by -1.15%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down by -0.83%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down by -1.32%. September E-mini S&P futures (ESU25 ) are down -1.15%, and September... - 2025-09-02 13:49:14
Stocks Tumble on Higher Bond Yields: The S&P 500 Index ($SPX ) (SPY ) today is down by -1.26%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down by -1.23%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down by -1.38%. September E-mini S&P futures (ESU25 ) are down -1.25%, and September... - 2025-09-02 13:32:33
Stocks Tumble on Higher Bond Yields: The S&P 500 Index ($SPX ) (SPY ) today is down by -1.26%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down by -1.23%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down by -1.38%. September E-mini S&P futures (ESU25 ) are down -1.25%, and September... - 2025-09-02 12:50:37
United Therapeutics (NASDAQ:UTHR) EVP Paul Mahon Sells 11,000 Shares: United Therapeutics Corporation (NASDAQ:UTHR – Get Free Report) EVP Paul Mahon sold 11,000 shares of the company’s stock in a transaction dated Thursday, August 21st. The shares were sold at an average price of $308.75, for a total transaction of $3,396,250.00. Following the sale, the executive vice president directly owned 36,781 shares of the company’s […] - 2025-08-25 05:07:00
LABU, INCY, UTHR, REGN: ETF Outflow Alert: Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Direxion Daily S&P Biotech Bull 3x Shares (Symbol: LABU) where we have detected an approximate $67.3 million dollar outflow -- that's a 9.4% dec - 2025-08-20 12:04:03
Analysts Set United Therapeutics Corporation (NASDAQ:UTHR) PT at $379.69: United Therapeutics Corporation (NASDAQ:UTHR – Get Free Report) has earned an average recommendation of “Moderate Buy” from the thirteen research firms that are covering the stock, Marketbeat.com reports. Four analysts have rated the stock with a hold recommendation and nine have assigned a buy recommendation to the company. The average 1-year target price among analysts […] - 2025-08-15 02:40:53
Deutsche Bank AG Cuts Stake in United Therapeutics Corporation (NASDAQ:UTHR): Deutsche Bank AG lessened its position in United Therapeutics Corporation (NASDAQ:UTHR – Free Report) by 6.4% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 134,483 shares of the biotechnology company’s stock after selling 9,146 shares during the period. Deutsche Bank AG […] - 2025-08-13 04:52:49
Notable Thursday Option Activity: TGT, UTHR, ENPH: Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Target Corp (Symbol: TGT), where a total of 35,810 contracts have traded so far, representing approximately 3.6 million underlying shares. That amounts to about 72% of T - 2025-08-07 16:22:01
977 Shares in United Therapeutics Corporation (NASDAQ:UTHR) Purchased by Arkadios Wealth Advisors: Arkadios Wealth Advisors purchased a new stake in United Therapeutics Corporation (NASDAQ:UTHR – Free Report) in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 977 shares of the biotechnology company’s stock, valued at approximately $301,000. Other hedge funds and other institutional […] - 2025-08-07 05:06:52
Mackenzie Financial Corp Sells 51 Shares of United Therapeutics Corporation (NASDAQ:UTHR): Mackenzie Financial Corp trimmed its holdings in shares of United Therapeutics Corporation (NASDAQ:UTHR – Free Report) by 1.9% during the first quarter, Holdings Channel.com reports. The institutional investor owned 2,606 shares of the biotechnology company’s stock after selling 51 shares during the quarter. Mackenzie Financial Corp’s holdings in United Therapeutics were worth $803,000 at the […] - 2025-08-06 05:07:40

iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) UTHR holdings

Date	Number of UTHR Shares Held	Base Market Value of UTHR Shares	Local Market Value of UTHR Shares	Change in UTHR Shares Held	Change in UTHR Base Value	Current Price per UTHR Share Held	Previous Price per UTHR Share Held
2025-11-11 (Tuesday)	29,333	USD 13,470,007	USD 13,470,007	0	USD 154,878	USD 459.21	USD 453.93
2025-11-10 (Monday)	29,333	USD 13,315,129	USD 13,315,129	75	USD 180,920	USD 453.93	USD 448.91
2025-11-07 (Friday)	29,258	USD 13,134,209	USD 13,134,209	0	USD -148,923	USD 448.91	USD 454
2025-11-06 (Thursday)	29,258	USD 13,283,132	USD 13,283,132	75	USD 225,199	USD 454	USD 447.45
2025-11-05 (Wednesday)	29,183	USD 13,057,933	USD 13,057,933	0	USD 295,332	USD 447.45	USD 437.33
2025-11-04 (Tuesday)	29,183	USD 12,762,601	USD 12,762,601	75	USD -5,914	USD 437.33	USD 438.66
2025-11-03 (Monday)	29,108	USD 12,768,515	USD 12,768,515	0	USD -197,061	USD 438.66	USD 445.43
2025-10-31 (Friday)	29,108	USD 12,965,576	USD 12,965,576	0	USD -235,775	USD 445.43	USD 453.53
2025-10-30 (Thursday)	29,108	USD 13,201,351	USD 13,201,351	375	USD 118,641	USD 453.53	USD 455.32
2025-10-29 (Wednesday)	28,733	USD 13,082,710	USD 13,082,710	237	USD 1,247,181	USD 455.32	USD 415.34
2025-10-28 (Tuesday)	28,496	USD 11,835,529	USD 11,835,529	0	USD -162,427	USD 415.34	USD 421.04
2025-10-27 (Monday)	28,496	USD 11,997,956	USD 11,997,956	0	USD 70,100	USD 421.04	USD 418.58

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of UTHR by Blackrock for IE00BYXG2H39

Show aggregate share trades of UTHR

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-11-10 BUY 75 453.930* 342.07
2025-11-06 BUY 75 454.000* 340.99
2025-11-04 BUY 75 437.330* 339.98
2025-10-30 BUY 375 456.745 445.980 447.057 USD 167,646 338.36
2025-10-29 BUY 237 455.320 479.500 477.082 USD 113,068 337.77
2025-10-22 SELL -300 421.640 424.120 423.872 USD -127,162 335.60 Loss of -26,481 on sale
2025-10-20 BUY 150 432.690 436.000 435.669 USD 65,350 334.63
2025-10-17 BUY 375 433.340 435.380 435.176 USD 163,191 334.10
2025-10-15 BUY 600 432.190 441.780 440.821 USD 264,493 333.58
2025-10-03 BUY 518 453.070 455.120 454.915 USD 235,646 332.39
2025-10-02 BUY 74 443.440 444.570 444.457 USD 32,890 331.79
2025-09-30 BUY 148 419.210 428.420 427.499 USD 63,270 330.72
2025-09-26 BUY 148 432.660 433.570 433.479 USD 64,155 329.64
2025-09-25 BUY 148 425.420 437.680 436.454 USD 64,595 329.10
2025-09-24 SELL -1,206 438.750 442.010 441.684 USD -532,671 328.48 Loss of -136,518 on sale
2025-09-18 BUY 78 409.870 410.530 410.464 USD 32,016 328.02
2025-09-17 BUY 234 403.680 405.410 405.237 USD 94,825 327.60
2025-09-11 SELL -78 404.840 405.460 405.398 USD -31,621 326.75 Loss of -6,135 on sale
2025-09-10 BUY 156 396.500 405.340 404.456 USD 63,095 326.34
2025-09-05 SELL -78 400.520 401.620 401.510 USD -31,318 325.05 Loss of -5,964 on sale
2025-08-20 SELL -312 306.480 314.980 314.130 USD -98,009 325.37 Profit of 3,506 on sale
2025-08-18 BUY 156 314.100 316.210 315.999 USD 49,296 325.51
2025-07-30 BUY 312 281.950 300.490 298.636 USD 93,174 326.43
2025-07-17 SELL -156 297.330 302.520 302.001 USD -47,112 328.06 Profit of 4,065 on sale
2025-07-16 BUY 272 298.160 299.830 299.663 USD 81,508 328.26
2025-07-11 SELL -616 295.520 298.960 298.616 USD -183,947 328.93 Profit of 18,672 on sale
2025-07-07 BUY 231 290.390 294.300 293.909 USD 67,893 329.84
2025-07-02 BUY 4,235 295.220 295.980 295.904 USD 1,253,153 330.33
2025-06-20 BUY 668 290.750 293.770 293.468 USD 196,037 330.62
2025-06-13 BUY 96 283.350 287.120 286.743 USD 27,527 332.18
2025-06-11 BUY 148 276.470 288.560 287.351 USD 42,528 332.94
2025-06-10 BUY 148 281.360 292.700 291.566 USD 43,152 333.33
2025-06-04 SELL -74 323.970 335.000 333.897 USD -24,708 333.61 Loss of -21 on sale
2025-04-23 BUY 74 293.460 298.300 297.816 USD 22,038 342.10
2025-04-10 SELL -600 278.890 287.440 286.585 USD -171,951 347.92 Profit of 36,801 on sale
2025-04-08 SELL -75 279.690 304.810 302.298 USD -22,672 349.34 Profit of 3,528 on sale
2025-04-07 SELL -75 291.720 299.070 298.335 USD -22,375 350.01 Profit of 3,875 on sale
2025-04-04 SELL -375 292.460 308.100 306.536 USD -114,951 350.68 Profit of 16,556 on sale
2025-04-01 BUY 641 306.880 311.550 311.083 USD 199,404 351.68
2025-03-31 SELL -219 308.270 309.640 309.503 USD -67,781 352.20 Profit of 9,352 on sale
2025-03-21 BUY 1,019 312.990 315.690 315.420 USD 321,413 355.33
2025-03-14 SELL -1,120 307.240 310.170 309.877 USD -347,062 358.15 Profit of 54,065 on sale
2025-03-07 SELL -140 315.910 320.810 320.320 USD -44,845 361.79 Profit of 5,805 on sale
2025-03-04 SELL -70 308.590 315.530 314.836 USD -22,039 364.30 Profit of 3,462 on sale
2025-02-25 BUY 140 357.500 364.980 364.232 USD 50,992 367.60
2025-02-19 SELL -70 380.780 383.510 383.237 USD -26,827 367.65 Loss of -1,091 on sale
2025-02-13 BUY 210 370.440 372.690 372.465 USD 78,218 367.37
2025-02-12 BUY 70 370.740 370.890 370.875 USD 25,961 367.31
2025-02-11 BUY 280 353.310 363.000 362.031 USD 101,369 367.60
2025-01-02 BUY 67 360.220 360.970 360.895 USD 24,180 371.05
2024-12-30 SELL -2,413 357.640 361.440 361.060 USD -871,238 371.46 Profit of 25,095 on sale
2024-11-18 SELL -1,140 359.210 363.000 362.621 USD -413,388 373.42 Profit of 12,308 on sale
2024-11-08 SELL -76 410.000 417.820 417.038 USD -31,695 368.84 Loss of -3,663 on sale
2024-10-21 SELL -76 370.600 372.720 372.508 USD -28,311 0.00 Loss of -28,311 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-11-10	BUY	75			453.930*		342.07
2025-11-06	BUY	75			454.000*		340.99
2025-11-04	BUY	75			437.330*		339.98
2025-10-30	BUY	375	456.745	445.980	447.057	USD 167,646	338.36
2025-10-29	BUY	237	455.320	479.500	477.082	USD 113,068	337.77
2025-10-22	SELL	-300	421.640	424.120	423.872	USD -127,162	335.60 Loss of -26,481 on sale
2025-10-20	BUY	150	432.690	436.000	435.669	USD 65,350	334.63
2025-10-17	BUY	375	433.340	435.380	435.176	USD 163,191	334.10
2025-10-15	BUY	600	432.190	441.780	440.821	USD 264,493	333.58
2025-10-03	BUY	518	453.070	455.120	454.915	USD 235,646	332.39
2025-10-02	BUY	74	443.440	444.570	444.457	USD 32,890	331.79
2025-09-30	BUY	148	419.210	428.420	427.499	USD 63,270	330.72
2025-09-26	BUY	148	432.660	433.570	433.479	USD 64,155	329.64
2025-09-25	BUY	148	425.420	437.680	436.454	USD 64,595	329.10
2025-09-24	SELL	-1,206	438.750	442.010	441.684	USD -532,671	328.48 Loss of -136,518 on sale
2025-09-18	BUY	78	409.870	410.530	410.464	USD 32,016	328.02
2025-09-17	BUY	234	403.680	405.410	405.237	USD 94,825	327.60
2025-09-11	SELL	-78	404.840	405.460	405.398	USD -31,621	326.75 Loss of -6,135 on sale
2025-09-10	BUY	156	396.500	405.340	404.456	USD 63,095	326.34
2025-09-05	SELL	-78	400.520	401.620	401.510	USD -31,318	325.05 Loss of -5,964 on sale
2025-08-20	SELL	-312	306.480	314.980	314.130	USD -98,009	325.37 Profit of 3,506 on sale
2025-08-18	BUY	156	314.100	316.210	315.999	USD 49,296	325.51
2025-07-30	BUY	312	281.950	300.490	298.636	USD 93,174	326.43
2025-07-17	SELL	-156	297.330	302.520	302.001	USD -47,112	328.06 Profit of 4,065 on sale
2025-07-16	BUY	272	298.160	299.830	299.663	USD 81,508	328.26
2025-07-11	SELL	-616	295.520	298.960	298.616	USD -183,947	328.93 Profit of 18,672 on sale
2025-07-07	BUY	231	290.390	294.300	293.909	USD 67,893	329.84
2025-07-02	BUY	4,235	295.220	295.980	295.904	USD 1,253,153	330.33
2025-06-20	BUY	668	290.750	293.770	293.468	USD 196,037	330.62
2025-06-13	BUY	96	283.350	287.120	286.743	USD 27,527	332.18
2025-06-11	BUY	148	276.470	288.560	287.351	USD 42,528	332.94
2025-06-10	BUY	148	281.360	292.700	291.566	USD 43,152	333.33
2025-06-04	SELL	-74	323.970	335.000	333.897	USD -24,708	333.61 Loss of -21 on sale
2025-04-23	BUY	74	293.460	298.300	297.816	USD 22,038	342.10
2025-04-10	SELL	-600	278.890	287.440	286.585	USD -171,951	347.92 Profit of 36,801 on sale
2025-04-08	SELL	-75	279.690	304.810	302.298	USD -22,672	349.34 Profit of 3,528 on sale
2025-04-07	SELL	-75	291.720	299.070	298.335	USD -22,375	350.01 Profit of 3,875 on sale
2025-04-04	SELL	-375	292.460	308.100	306.536	USD -114,951	350.68 Profit of 16,556 on sale
2025-04-01	BUY	641	306.880	311.550	311.083	USD 199,404	351.68
2025-03-31	SELL	-219	308.270	309.640	309.503	USD -67,781	352.20 Profit of 9,352 on sale
2025-03-21	BUY	1,019	312.990	315.690	315.420	USD 321,413	355.33
2025-03-14	SELL	-1,120	307.240	310.170	309.877	USD -347,062	358.15 Profit of 54,065 on sale
2025-03-07	SELL	-140	315.910	320.810	320.320	USD -44,845	361.79 Profit of 5,805 on sale
2025-03-04	SELL	-70	308.590	315.530	314.836	USD -22,039	364.30 Profit of 3,462 on sale
2025-02-25	BUY	140	357.500	364.980	364.232	USD 50,992	367.60
2025-02-19	SELL	-70	380.780	383.510	383.237	USD -26,827	367.65 Loss of -1,091 on sale
2025-02-13	BUY	210	370.440	372.690	372.465	USD 78,218	367.37
2025-02-12	BUY	70	370.740	370.890	370.875	USD 25,961	367.31
2025-02-11	BUY	280	353.310	363.000	362.031	USD 101,369	367.60
2025-01-02	BUY	67	360.220	360.970	360.895	USD 24,180	371.05
2024-12-30	SELL	-2,413	357.640	361.440	361.060	USD -871,238	371.46 Profit of 25,095 on sale
2024-11-18	SELL	-1,140	359.210	363.000	362.621	USD -413,388	373.42 Profit of 12,308 on sale
2024-11-08	SELL	-76	410.000	417.820	417.038	USD -31,695	368.84 Loss of -3,663 on sale
2024-10-21	SELL	-76	370.600	372.720	372.508	USD -28,311	0.00 Loss of -28,311 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of UTHR

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	153,866	0	219,485	70.1%
2025-09-18	150,660	507	244,012	61.7%
2025-09-17	118,604	0	203,933	58.2%
2025-09-16	98,017	0	152,204	64.4%
2025-09-15	194,904	1,100	272,093	71.6%
2025-09-12	140,200	312	215,877	64.9%
2025-09-11	130,761	0	185,960	70.3%
2025-09-10	93,471	0	167,479	55.8%
2025-09-09	130,474	5,137	237,469	54.9%
2025-09-08	133,051	155	197,596	67.3%
2025-09-05	208,712	0	305,636	68.3%
2025-09-04	267,014	2,931	447,449	59.7%
2025-09-03	353,287	6,339	607,921	58.1%
2025-09-02	588,583	649	1,051,870	56.0%
2025-08-29	83,066	0	153,416	54.1%
2025-08-28	189,688	0	274,930	69.0%
2025-08-27	106,544	0	190,443	55.9%
2025-08-26	205,626	1	291,359	70.6%
2025-08-25	169,978	50	284,574	59.7%
2025-08-22	111,768	0	168,756	66.2%
2025-08-21	108,127	700	171,869	62.9%
2025-08-20	97,311	0	233,032	41.8%
2025-08-19	101,665	0	173,996	58.4%
2025-08-18	117,218	0	198,427	59.1%
2025-08-15	102,775	400	182,428	56.3%
2025-08-14	111,383	2	241,644	46.1%
2025-08-13	121,320	20	207,808	58.4%
2025-08-12	119,055	0	255,456	46.6%
2025-08-11	66,961	2	172,485	38.8%
2025-08-08	80,618	0	168,980	47.7%
2025-08-07	127,929	300	188,828	67.7%
2025-08-06	133,246	0	198,721	67.1%
2025-08-05	167,281	0	265,699	63.0%
2025-08-04	129,417	0	261,825	49.4%
2025-08-01	233,117	0	390,876	59.6%
2025-07-31	124,812	82	221,740	56.3%
2025-07-30	202,980	2,630	356,973	56.9%
2025-07-29	86,445	121	209,016	41.4%
2025-07-28	88,897	370	186,606	47.6%
2025-07-25	62,507	0	105,428	59.3%
2025-07-24	87,550	1,026	144,035	60.8%
2025-07-23	91,947	14	184,045	50.0%
2025-07-22	60,147	0	122,296	49.2%
2025-07-21	77,937	42	134,589	57.9%
2025-07-18	68,061	154	93,661	72.7%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
Issuer	Blackrock
Entity holding fund	iShares IV Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300ZP07LMR36K1T02
ETF Ticker	BTEC(USD) LSE
ETF Ticker	BTEK(GBP) LSE
ETF Ticker	2B70(EUR) F
ETF Ticker	2B70.DE(EUR) CXE
ETF Ticker	BTEC.LS(USD) CXE
ETF Ticker	BTEK.LS(GBP) CXE
ETF Ticker	BTEC.L(GBP) LSE
ETF Ticker	BTEK.L(GBP) LSE